PlumeStars actively participated at the 57th AFI Symposium, the Italian Conference of the Industrial Pharmacists, held on 7-8 and 9 June at the Pala Congressi in Rimini. The symposium has registered more than 1000 attendees and more than 100 stands, reconfirming itself as a meeting point for excellence which revolves around the pharmaceutical world.
The 57th AFI Symposium organized the “Startup Square”, an area specifically dedicated within the exhibition space and accessible for free to allow visitors and companies to come in direct contact with the innovative realities present.
PlumeStars presented in a speech of Prof. Paolo Colombo (PlumeStars CEO) The Orphan Medicine Initiative, describing important achievements in the field of orphan medicines. The novel orphan medicines presented in Rimini were:
- Amikacin & tobramycin powders for inhalations in cystic fibrosis
- Cisplatin films for local delivery in mesothelioma recurrences
- Thalidomide powder for oral and nasal delivery in Hereditary Haemorrhagic Telangiectasia.
